Cargando…
Serum Procalcitonin and Procalcitonin Clearance as a Prognostic Biomarker in Patients with Severe Sepsis and Septic Shock
We evaluated the tendency of the plasma concentration and procalcitonin (PCT) clearance (PCTc) to act as biomarkers of prognosis in patients with severe sepsis and septic shock. From 2011 to 2013, we prospectively analyzed patients with sepsis admitted to the intensive care unit (ICU). The serum PCT...
Autores principales: | Huang, Min-Yi, Chen, Chun-Yu, Chien, Ju-Huei, Wu, Kun-Hsi, Chang, Yu-Jun, Wu, Kang-Hsi, Wu, Han-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818793/ https://www.ncbi.nlm.nih.gov/pubmed/27088084 http://dx.doi.org/10.1155/2016/1758501 |
Ejemplares similares
-
Procalcitonin as a prognostic biomarker of severe sepsis and septic shock
por: de Azevedo, JRA, et al.
Publicado: (2013) -
Procalcitonin kinetics as a prognostic marker in severe sepsis/septic shock
por: Poddar, Banani, et al.
Publicado: (2015) -
Procalcitonin-guided therapy in severe sepsis and septic shock
por: Gu, Wan-Jie, et al.
Publicado: (2014) -
Pentraxin-3, procalcitonin and lactate as prognostic markers in patients with sepsis and septic shock
por: Hu, Chenggong, et al.
Publicado: (2017) -
Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
por: Brunkhorst, FM, et al.
Publicado: (1999)